Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from iSpecimen ( (ISPC) ) is now available.
iSpecimen Inc. convened its 2025 Annual Meeting of Stockholders on December 31, 2025, but repeatedly lacked a quorum, forcing adjournments on January 23, February 13, March 13, and April 10, 2026. The company plans to reconvene the meeting on May 8, 2026, maintaining November 3, 2025 as the record date and keeping all proxy proposals unchanged, signaling ongoing efforts to secure sufficient shareholder participation for required corporate decisions.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
ISPC scores low primarily due to sharply deteriorating fundamentals (revenue decline, margin collapse, very large losses) and ongoing operating/free-cash-flow burn. Technicals also remain bearish with the price below all key moving averages and negative MACD, despite oversold readings. Corporate events are mixed, and valuation metrics provide limited support given negative earnings and no dividend yield.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
iSpecimen Inc. operates as a corporation serving stockholders in the public markets, with governance overseen through annual meetings at which investors vote on key proposals detailed in proxy materials. The company’s corporate actions and shareholder engagement are structured around record dates and formal SEC filings to ensure compliance and orderly decision-making.
Average Trading Volume: 14,983,067
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.8M
Learn more about ISPC stock on TipRanks’ Stock Analysis page.